Results 21 to 30 of about 7,952,783 (243)

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α

open access: yesPharmaceutics, 2022
The blood–brain tumor barrier represents a major obstacle for anticancer drug delivery to brain tumors. Thus, novel strategies aimed at targeting and breaching this structure are of great experimental and clinical interest.
Angelo Corti   +3 more
doaj   +1 more source

Targeting smooth muscle cell phenotypic switching in vascular disease

open access: yesJVS: Vascular Science, 2021
Objective The phenotypic plasticity of vascular smooth muscle cells (VSMCs) is central to vessel growth and remodeling, but also contributes to cardiovascular pathologies.
Raja Chakraborty   +6 more
semanticscholar   +1 more source

Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2021
Purpose: Tumor vascular targeting appeared as an appealing approach to fight cancer, though, the results from the clinical trials and drugs in the market were proved otherwise.
Amir Daei Farshchi Adli   +5 more
doaj   +1 more source

Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy

open access: yesCell Reports, 2020
Summary: Due to limited current therapies, metastases are the primary cause of mortality in cancer patients. Here, we employ a fusion compound of the cytokine LIGHT and a vascular targeting peptide (LIGHT-VTP) that homes to angiogenic blood vessels in ...
Bo He   +6 more
doaj   +1 more source

Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides

open access: yesPharmaceutics, 2022
Modification with polyethylene glycol (PEGylation) and the use of rigid phospholipids drastically improve the pharmacokinetics of chemotherapeutics and result in more manageable or reduced side-effects.
Mohamadreza Amin   +5 more
doaj   +1 more source

Light-enhanced VEGF121/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment

open access: yesFrontiers in Immunology, 2023
BackgroundImmune-checkpoint inhibitors (ICIs) represent a revolution in cancer therapy and are currently implemented as standard therapy within several cancer indications.
Ane Sager Longva   +2 more
doaj   +1 more source

microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. [PDF]

open access: yes, 2014
BackgroundmicroRNA (miRNA) are important regulators of gene expression. In patients with ischemic stroke we have previously shown that differences in immune cell gene expression are present.
Ander, Bradley P   +5 more
core   +5 more sources

Regional diversity in the murine cortical vascular network is revealed by synchrotron X-ray tomography and is amplified with age [PDF]

open access: yes, 2018
Cortical bone is permeated by a system of pores, occupied by the blood supply and osteocytes. With ageing, bone mass reduction and disruption of the microstructure are associated with reduced vascular supply.
A Goring   +10 more
core   +5 more sources

Tumour vessel remodelling: new opportunities in cancer treatment

open access: yesVascular Biology, 2020
Tumour growth critically depends on a supportive microenvironment, including the tumour vasculature. Tumour blood vessels are structurally abnormal and functionally anergic which limits drug access and immune responses in solid cancers.
Ruth Ganss
doaj   +1 more source

Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms [PDF]

open access: yes, 2018
Hypertension and type 2 diabetes are common comorbidities. Hypertension is twice as frequent in patients with diabetes compared with those who do not have diabetes.
Guzik, Tomasz J.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy